Capital International Investors - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital International Investors ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$30,140,000
+19.5%
1,545,6300.0%0.01%
+40.0%
Q4 2021$25,225,000
-41.4%
1,545,6300.0%0.01%
-50.0%
Q3 2021$43,061,000
-6.0%
1,545,6300.0%0.01%0.0%
Q2 2021$45,812,000
+6.0%
1,545,6300.0%0.01%
-9.1%
Q1 2021$43,200,000
+31.2%
1,545,630
+33.0%
0.01%
+22.2%
Q4 2020$32,928,000
+12.7%
1,161,9000.0%0.01%0.0%
Q3 2020$29,210,000
+2.9%
1,161,9000.0%0.01%0.0%
Q2 2020$28,374,000
+65.0%
1,161,9000.0%0.01%
+28.6%
Q1 2020$17,196,000
-8.8%
1,161,9000.0%0.01%
+16.7%
Q4 2019$18,858,000
+346.3%
1,161,900
+257.5%
0.01%
+200.0%
Q3 2019$4,225,000
+0.2%
325,0000.0%0.00%0.0%
Q2 2019$4,215,000
-17.7%
325,0000.0%0.00%0.0%
Q1 2019$5,122,000
-21.7%
325,0000.0%0.00%
-33.3%
Q4 2018$6,542,000
-19.0%
325,0000.0%0.00%
-25.0%
Q3 2018$8,076,000325,0000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,415,689$86,106,0006.66%
Evolutionary Tree Capital Management, LLC 176,336$3,439,0002.39%
Essex Woodlands Management, Inc. 457,085$8,913,0002.16%
HealthCor Management, L.P. 1,423,425$27,757,0001.85%
RICE HALL JAMES & ASSOCIATES, LLC 1,112,325$21,690,0000.86%
Waypoint Capital Advisors, LLC 53,989$1,016,0000.60%
Antara Capital LP 679,600$13,252,0000.40%
Rhenman & Partners Asset Management AB 198,358$3,868,0000.38%
Walleye Capital LLC 505,701$9,861,0000.26%
Polar Capital Holdings Plc 2,456,497$47,902,0000.22%
View complete list of REVANCE THERAPEUTICS INC shareholders